Hangzhou Jirui Technology Co., Ltd.

Hangzhou Jirui Technology Co., Ltd. was established in September 2018.₹ It is an innovative biomedical enterprise specializing in ™the automatic synthesis platform of nuclear medicine molec∏ular imaging tracer drugs, research and development, production and sales of radiopharmaceuti∏cals. The company has set up a research and development team compo≥sed of high-level talents at home and abroad, such as Zhejiang University an✔d UCLA. Relying on the R & D resources of the Key Laboratory§ of Medical Molecular Imaging of Zhejiang Province and the Key Laboratory ↓of Biomedical Engineering of the Ministry of Education of Zhejiang University, based on the nu€clear medicine industry, focusing on independent research and development, and cooperat¥ing with external cooperation models, in tumors, cardiovascular and cerebrovascular disea ses, Neurodegenerative diseases and other fields have gradually created a full-chain dev≈elopment pattern integrating nuclear medicine molecular imaging tracer synthesis devices" and nuclear medicine (diagnostic and therapeutic) R &a✔mp; D, production and sales.

視(shì)頻(pín)标題

The company has developed multiple sets of nuclear medicin₩e molecular imaging tracer drug fully automatic synthesis platforms, which are modular, ≠multifunctional, and easy to operate. They are suitable for high-throughput prep★aration of radioactive drugs with different synthesis paths and meet strict clinicaσl quality control requirements. At the same time, various new nuclide labeled positron emissio‌n tomography tracers and new preparation processes have been succ₽essfully developed, such as [18F]-Safranamide，[18F]-FHBG, [18F]-MK9470 and others have significant application value $in the mechanism research and diagnosis of major diseases such as tumors, cardiov★ascular and cerebrovascular diseases, and neurodegeneration. Forming an industrial≤ layout with the design and manufacturing of automa<tic synthesis systems for radioactive drugs, as well as t←he research and development, design, and production of new PET tracers as the core c¥ompetition.

As a fast-growing technology enterprise, the company's brand value i♦s gradually formed in the field of nuclear medicine imaging. ¶We will continue to uphold the core values of innovationε, professionalism and responsibility, and continue to strive for exce↕llence and contribute to the cause of human health. We welcomσe people with lofty ideals to join us and work together to build a better future.